West Nile-Innovator + EWT (Canada)

Company: Zoetis

Encephalomyelitis-West Nile Virus Vaccine

Eastern & Western, Killed Virus

Tetanus Toxoid

This product has been shown to be effective for the vaccination of healthy horses 10 months of age or older against viremia caused by West Nile virus; encephalomyelitis caused by Eastern and Western viruses; and tetanus. A duration of immunity of at least 12 months against West Nile virus has been demonstrated. Duration of immunity against the remaining fractions is unknown. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Field safety testing has demonstrated that this product is safe for use in horses 3 months of age or older. Efficacy has not been established in foals 3 months of age. This product is also safe for use as a single dose during the third trimester of pregnancy.

Directions For Use

Shake well. Aseptically administer 1 mL intramuscularly. Healthy horses should receive two doses administered 3-4 weeks apart. For advice on revaccination frequency or in the face of stress or exposure, contact your veterinarian or the manufacturer.

Precautions

Store at 2°-8°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Use entire contents when first opened. Transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. Contains formalin, thimerosal, neomycin, and polymyxin B as preservatives. Do not mix with other products. In case of human exposure, contact a physician.

Technical inquiries should be directed to Zoetis Canada Inc. Veterinary Services, (800) 461-0917.

For veterinary use only.

Remove serial number and expiration date label and place on the animal’s medical chart.

VLN 190/PCN 48W5.24

Zoetis Inc., Kalamazoo, MI 49007, USA

CPN: 1198428.3